AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2019

Aug 14, 2019

30073_dirs_2019-08-14_cecf43b9-eab5-41bf-9c95-c8fbef98413f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-08-12

Reporting Person: Glazer Donald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-12	American Depositary Shares	J	13384	—	Disposed	0	Direct
2019-08-12	Ordinary Shares	J	26100	—	Disposed	3711426	Direct

Footnotes

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The reporting person transferred these American Depositary Shares to his spouse pursuant to a divorce decree effective at a future date.

F3: The reporting person transferred these ordinary shares to his spouse pursuant to a divorce decree effective at a future date. The reporting person no longer reports as beneficially owned any securities owned by his spouse.